Potential new urinary markers in the early detection of bladder cancer

Samir P. Shirodkar, Vinata B Lokeshwar

Research output: Contribution to journalReview article

56 Citations (Scopus)

Abstract

PURPOSE OF REVIEW: Bladder cancer remains a highly prevalent and lethal malignancy. Early diagnosis and prompt treatment have been shown to improve survival at both initial diagnosis and recurrence. A vast number of tumor markers have been identified and rigorously evaluated in attempts to improve noninvasive diagnostic accuracy of bladder cancer. Hematuria was the first tumor marker in a field that has grown to include soluble markers, cell-surface antigens, cell-cycle-related proteins, and genetic alterations. We aim to provide a critical appraisal of newer markers and the current state of research. RECENT FINDINGS: The number of tumor markers identified has been exponentially increasing. For a variety of reasons, many are unsuitable for clinical practice. More promising recent markers include those discovered in the fields of genomics, proteomics, and epigenetics. Much of the recent work is focused on molecular genetic pathways in bladder cancer. SUMMARY: The field of bladder cancer tumor markers remains a rapidly evolving area in which newer markers are constantly identified, evaluated, and often discarded if they do not add significantly to the urologists' armamentarium. Newer markers rely on genetic rearrangements, molecular changes, and cell-cycle-related proteins. Work is currently being done to identify the most promising markers.

Original languageEnglish (US)
Pages (from-to)488-493
Number of pages6
JournalCurrent Opinion in Urology
Volume19
Issue number5
DOIs
StatePublished - Sep 1 2009

Fingerprint

Early Detection of Cancer
Urinary Bladder Neoplasms
Tumor Biomarkers
Cell Cycle Proteins
Molecular Biology
Hematuria
Surface Antigens
Genomics
Epigenomics
Proteomics
Early Diagnosis
Recurrence
Research
Neoplasms
Therapeutics

Keywords

  • Bladder cancer
  • Molecular diagnostics
  • Tumor markers

ASJC Scopus subject areas

  • Urology

Cite this

Potential new urinary markers in the early detection of bladder cancer. / Shirodkar, Samir P.; Lokeshwar, Vinata B.

In: Current Opinion in Urology, Vol. 19, No. 5, 01.09.2009, p. 488-493.

Research output: Contribution to journalReview article

@article{b5d1fac586964c32bd8f8c7aed3013c7,
title = "Potential new urinary markers in the early detection of bladder cancer",
abstract = "PURPOSE OF REVIEW: Bladder cancer remains a highly prevalent and lethal malignancy. Early diagnosis and prompt treatment have been shown to improve survival at both initial diagnosis and recurrence. A vast number of tumor markers have been identified and rigorously evaluated in attempts to improve noninvasive diagnostic accuracy of bladder cancer. Hematuria was the first tumor marker in a field that has grown to include soluble markers, cell-surface antigens, cell-cycle-related proteins, and genetic alterations. We aim to provide a critical appraisal of newer markers and the current state of research. RECENT FINDINGS: The number of tumor markers identified has been exponentially increasing. For a variety of reasons, many are unsuitable for clinical practice. More promising recent markers include those discovered in the fields of genomics, proteomics, and epigenetics. Much of the recent work is focused on molecular genetic pathways in bladder cancer. SUMMARY: The field of bladder cancer tumor markers remains a rapidly evolving area in which newer markers are constantly identified, evaluated, and often discarded if they do not add significantly to the urologists' armamentarium. Newer markers rely on genetic rearrangements, molecular changes, and cell-cycle-related proteins. Work is currently being done to identify the most promising markers.",
keywords = "Bladder cancer, Molecular diagnostics, Tumor markers",
author = "Shirodkar, {Samir P.} and Lokeshwar, {Vinata B}",
year = "2009",
month = "9",
day = "1",
doi = "10.1097/MOU.0b013e32832eb3a0",
language = "English (US)",
volume = "19",
pages = "488--493",
journal = "Current Opinion in Urology",
issn = "0963-0643",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Potential new urinary markers in the early detection of bladder cancer

AU - Shirodkar, Samir P.

AU - Lokeshwar, Vinata B

PY - 2009/9/1

Y1 - 2009/9/1

N2 - PURPOSE OF REVIEW: Bladder cancer remains a highly prevalent and lethal malignancy. Early diagnosis and prompt treatment have been shown to improve survival at both initial diagnosis and recurrence. A vast number of tumor markers have been identified and rigorously evaluated in attempts to improve noninvasive diagnostic accuracy of bladder cancer. Hematuria was the first tumor marker in a field that has grown to include soluble markers, cell-surface antigens, cell-cycle-related proteins, and genetic alterations. We aim to provide a critical appraisal of newer markers and the current state of research. RECENT FINDINGS: The number of tumor markers identified has been exponentially increasing. For a variety of reasons, many are unsuitable for clinical practice. More promising recent markers include those discovered in the fields of genomics, proteomics, and epigenetics. Much of the recent work is focused on molecular genetic pathways in bladder cancer. SUMMARY: The field of bladder cancer tumor markers remains a rapidly evolving area in which newer markers are constantly identified, evaluated, and often discarded if they do not add significantly to the urologists' armamentarium. Newer markers rely on genetic rearrangements, molecular changes, and cell-cycle-related proteins. Work is currently being done to identify the most promising markers.

AB - PURPOSE OF REVIEW: Bladder cancer remains a highly prevalent and lethal malignancy. Early diagnosis and prompt treatment have been shown to improve survival at both initial diagnosis and recurrence. A vast number of tumor markers have been identified and rigorously evaluated in attempts to improve noninvasive diagnostic accuracy of bladder cancer. Hematuria was the first tumor marker in a field that has grown to include soluble markers, cell-surface antigens, cell-cycle-related proteins, and genetic alterations. We aim to provide a critical appraisal of newer markers and the current state of research. RECENT FINDINGS: The number of tumor markers identified has been exponentially increasing. For a variety of reasons, many are unsuitable for clinical practice. More promising recent markers include those discovered in the fields of genomics, proteomics, and epigenetics. Much of the recent work is focused on molecular genetic pathways in bladder cancer. SUMMARY: The field of bladder cancer tumor markers remains a rapidly evolving area in which newer markers are constantly identified, evaluated, and often discarded if they do not add significantly to the urologists' armamentarium. Newer markers rely on genetic rearrangements, molecular changes, and cell-cycle-related proteins. Work is currently being done to identify the most promising markers.

KW - Bladder cancer

KW - Molecular diagnostics

KW - Tumor markers

UR - http://www.scopus.com/inward/record.url?scp=68949183335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68949183335&partnerID=8YFLogxK

U2 - 10.1097/MOU.0b013e32832eb3a0

DO - 10.1097/MOU.0b013e32832eb3a0

M3 - Review article

VL - 19

SP - 488

EP - 493

JO - Current Opinion in Urology

JF - Current Opinion in Urology

SN - 0963-0643

IS - 5

ER -